Log in
Enquire now
‌

US Patent 8193357 Androgen receptor modulator compounds

Patent 8193357 was granted and assigned to Ligand Pharmaceuticals on June, 2012 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent
0

Patent attributes

Current Assignee
Ligand Pharmaceuticals
Ligand Pharmaceuticals
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
81933570
Patent Inventor Names
Cornelis Arjan Van Oeveren0
Yixing Shen0
Shuo Zhao0
Bijan Pedram0
Lin Zhi0
Date of Patent
June 5, 2012
0
Patent Application Number
118832470
Date Filed
June 12, 2006
0
Patent Primary Examiner
‌
Janet Andres
0
Patent abstract

Provided herein are compounds that bind to androgen receptors and/or modulate activity of androgen receptors, and to methods for making and using such compounds. Also provided are compositions including such compounds and methods for making and using such compositions.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 8193357 Androgen receptor modulator compounds

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.